532 Views | 342 Downloads
Address correspondence to Joanna B. Goldberg, joanna.goldberg@emory.edu.
Reviewed by Stephen Lory, Solicited external reviewer and Daniel Wozniak, Solicited external reviewer.
We thank Jeffrey Meisner for purification of Wzz2 and construction of mini-CTX-optRBS-lacZ and Dominique Limoli for the isolation of CFBRPA32 and CFBRPA43 nonmucoid revertants.
Clinical isolates were obtained from the Cystic Fibrosis Biospecimen Registry (CFBR), which is maintained by Emory University and the Children’s Healthcare of Atlanta Center for Cystic Fibrosis and Airways Disease Research (CF-AIR).
This work was partially supported by a predoctoral fellowship to A.R.C. from the Cystic Fibrosis Foundation (CFF)-funded CF@LANTA RDP Center (MCCART15R0), CF-AIR, components of the Emory+Children’s CF Center of Excellence at Emory University, and Children’s Healthcare of Atlanta.
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under award number F31AI136310 also supported A.R.C.
Additional funding was awarded by the NIH and the CFF to J.B.G. under award numbers R21AI122192 and GOLDBE16G0, respectively.
© 2019 Cross and Goldberg.